DE60015151D1 - Neue zusammensetzungen zur kontrollierten freigabe eines biologisch wirksamen mittels sowie die herstellung derselben - Google Patents

Neue zusammensetzungen zur kontrollierten freigabe eines biologisch wirksamen mittels sowie die herstellung derselben

Info

Publication number
DE60015151D1
DE60015151D1 DE60015151T DE60015151T DE60015151D1 DE 60015151 D1 DE60015151 D1 DE 60015151D1 DE 60015151 T DE60015151 T DE 60015151T DE 60015151 T DE60015151 T DE 60015151T DE 60015151 D1 DE60015151 D1 DE 60015151D1
Authority
DE
Germany
Prior art keywords
biologically active
active agent
controlled release
production
new compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60015151T
Other languages
English (en)
Other versions
DE60015151T2 (de
Inventor
Manja Ahola
Eija Saeilynoja
Jukka Salonen
Risto Penttinen
Antti Yli-Urpo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioxid Oy
Original Assignee
Bioxid Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioxid Oy filed Critical Bioxid Oy
Application granted granted Critical
Publication of DE60015151D1 publication Critical patent/DE60015151D1/de
Publication of DE60015151T2 publication Critical patent/DE60015151T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
DE60015151T 1999-08-25 2000-08-22 Neue zusammensetzungen zur kontrollierten freigabe eines biologisch wirksamen mittels sowie die herstellung derselben Expired - Fee Related DE60015151T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI991806 1999-08-25
FI991806A FI19991806A (fi) 1999-08-25 1999-08-25 Uusia koostumuksia biologisesti aktiivisen aineen säädettyyn vapauttamiseen, ja niiden valmistus
PCT/FI2000/000710 WO2001013924A1 (en) 1999-08-25 2000-08-22 Novel compositions for controlled release of a biologically active agent, and the preparation thereof

Publications (2)

Publication Number Publication Date
DE60015151D1 true DE60015151D1 (de) 2004-11-25
DE60015151T2 DE60015151T2 (de) 2006-02-16

Family

ID=8555195

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60015151T Expired - Fee Related DE60015151T2 (de) 1999-08-25 2000-08-22 Neue zusammensetzungen zur kontrollierten freigabe eines biologisch wirksamen mittels sowie die herstellung derselben

Country Status (11)

Country Link
US (1) US7112339B1 (de)
EP (1) EP1206268B1 (de)
JP (1) JP2003507427A (de)
AT (1) ATE279928T1 (de)
AU (1) AU6705400A (de)
CA (1) CA2379982A1 (de)
DE (1) DE60015151T2 (de)
DK (1) DK1206268T3 (de)
ES (1) ES2230141T3 (de)
FI (1) FI19991806A (de)
WO (1) WO2001013924A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ573300A0 (en) * 2000-02-21 2000-03-16 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
US7758888B2 (en) 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
EP1372727B1 (de) 2001-04-04 2010-09-01 DelSiTech Oy Biologisch abbaubarer träger und verfahren zu seiner herstellung
EP1499890B1 (de) * 2002-05-07 2010-04-28 The Research Foundation of State University of New York "High througput" Methode, um Biomolekülanlieferung Formulierungen zu kennzeichnen
DE10249874A1 (de) * 2002-10-25 2004-05-06 Gesellschaft zur Förderung von Medizin-, Bio- und Umwelttechnologien e.V. Antiadhäsive Beschichtung zur Ausrüstung von Wundverbänden
WO2004081222A2 (en) 2003-03-14 2004-09-23 Sol-Gel Technologies Ltd. Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same
EP2263788B1 (de) 2003-07-31 2018-07-25 Sol-Gel Technologies Ltd. Eine verfahren zur herstellung von mikrokapseln die aktive stoff enthalten
US10149825B2 (en) * 2004-02-27 2018-12-11 Delsitech Oy Method for preparing adjustably bioresorbable sol-gel derived SiO2
GB0420016D0 (en) 2004-09-09 2004-10-13 Leuven K U Res & Dev Controlled release oral delivery system
JP5164840B2 (ja) 2005-08-02 2013-03-21 ソル − ゲル テクノロジーズ リミテッド 水不溶性成分の金属酸化物被覆
FI20070174A0 (fi) * 2007-02-28 2007-02-28 Delsitech Oy Menetelmä silikakoostumusten valmistamiseksi, silikakoostumukset ja niiden käytöt
US11458105B2 (en) 2008-12-04 2022-10-04 International Flavors & Fragrances Inc. Hybrid fragrance encapsulate formulation and method for using the same
US9763861B2 (en) 2008-12-04 2017-09-19 International Flavors & Fragrances Inc. Stable, flowable silica capsule formulation
KR101070345B1 (ko) 2009-07-03 2011-10-06 서울대학교산학협력단 생체활성인자가 포함된 유무기 혼성 복합 코팅층, 생체 이식용 임플란트 및 그 제조방법
ES2919933T3 (es) * 2011-03-18 2022-07-29 Int Flavors & Fragrances Inc Microcápsulas producidas a partir de precursores de sol-gel combinados y método de producción de las mismas
US9205150B2 (en) 2011-12-05 2015-12-08 Incept, Llc Medical organogel processes and compositions
KR102237799B1 (ko) 2012-11-14 2021-04-08 더블유.알. 그레이스 앤드 캄파니-콘. 생물학적 활성 물질 및 비-정렬된 무기 산화물을 함유하는 조성물
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804318A (en) * 1995-10-26 1998-09-08 Corvita Corporation Lubricious hydrogel surface modification
JP3488965B2 (ja) * 1996-05-21 2004-01-19 日本山村硝子株式会社 ゾル−ゲル法による独立膜の製造方法
HU227939B1 (en) * 1996-05-29 2012-06-28 Delsitech Oy Dissolvable oxides for biological applications
ATE368011T1 (de) 1999-02-22 2007-08-15 Delsitech Oy Biologisch abbaubaren keramischen fasern aus kiselsäuresol

Also Published As

Publication number Publication date
AU6705400A (en) 2001-03-19
DE60015151T2 (de) 2006-02-16
EP1206268B1 (de) 2004-10-20
ES2230141T3 (es) 2005-05-01
CA2379982A1 (en) 2001-03-01
JP2003507427A (ja) 2003-02-25
EP1206268A1 (de) 2002-05-22
ATE279928T1 (de) 2004-11-15
DK1206268T3 (da) 2005-01-10
FI19991806A (fi) 2001-02-26
WO2001013924A8 (en) 2001-11-01
US7112339B1 (en) 2006-09-26
WO2001013924A1 (en) 2001-03-01

Similar Documents

Publication Publication Date Title
DE60015151D1 (de) Neue zusammensetzungen zur kontrollierten freigabe eines biologisch wirksamen mittels sowie die herstellung derselben
RS49756B (sr) Primena ksenona ili smeša ksenonskog gasa za proizvodnju farmaceutskog preparata za lečenje neurointoksikacija
MXPA04001741A (es) Telas dispersables en agua sensibles al ion, un metodo y el uso de las mismas.
ATE477311T1 (de) Beschichtungszusammensetzung und verfahren
AU8841801A (en) Switchable tackiness coating compositions for ophthalmic implants
ATE268124T1 (de) Flüssige chitosan-enthaltende zusammensetzungen und verfahren zur herstellung und verwendung
DE60030777D1 (de) Durch ein sol-gel verfahren hergestellte bioaktive silicafasern und zugehörige verfahren und anwendungen
EE05091B1 (et) Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid
BRPI0511574A (pt) composição, método para depositar um poliéster de açúcar sobre um substrato, e, uso de uma composição
EP1420787B8 (de) Ascomycin enthaltende ophthalmische zubereitungen
AU6362100A (en) Derivatized polyurethane compositions and methods of making
DE60102850D1 (de) Verfahren zur Herstellung von wässrigen Beschichtungszusammensetzungen
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
EP1545605B8 (de) Zusammensetzung zur impfung
DE60042035D1 (de) Verfahren und zusammensetzungen zur herstellung von ophtalmischen linsen
WO2003062443A3 (en) Novel substituted alkane compounds and uses thereof
DE50206761D1 (de) Fluorhaltige copolymere, deren herstellung und verwendung
BR0213246A (pt) Composição aquosa, método para tratar um substrato poroso, artigo, e, composição resistente a mancha
MXPA04003755A (es) Endoprotesis vasculares.
NO20054088L (no) Vandig beleggingsmidler
MY128232A (en) Bleaching composition of enhanced stability and a process for making such a composition
DE60126918D1 (de) Dielektrische Keramikkomposition, Verfahren zur Herstellung eines Keramikkondensators, Verwendung eines keramischen Dielektrikums, und Keramikkondensator
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
WO2002070638A3 (en) Essential oil from.coleus forskohlii, production process and use as antimicrobial agent
DE60201074D1 (en) Pyrazolopyridinderivate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee